BioSpace News Archive

Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the company’s Chief Executive Officer, Talat Imran, will present at the 22nd Annual Needham Virtual Healthcare Conference on Tuesday, April 18, 2023 at 12:45 p.m. PT / 3:45 p.m. ET.

Intra-Cellular Therapies, Inc. announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 22nd Annual Needham Virtual Healthcare Conference on Tuesday, April 18, 2023 at 11:45 a.m. ET.

Catamaran Bio , Inc., a biotechnology company developing off-the-shelf natural killer (NK) cell therapies to treat cancer, today announced new data demonstrating preclinical pharmacology and in vivo efficacy from the Company’s two CAR-NK cell therapies in solid tumors have been selected for poster presentations during the American Association for Cancer Research (AACR) Annual Meeting taking place April 14-19, 2023, at the Orange County Convention Center in Orlando, FL.

Experts have found that at the start of the COVID-19 outbreak in early 2020, Americans chose not to become pregnant as they grappled with stay-at-home restrictions, anxiety, and economic hardship.

HUTCHMED Limited announces that Dr Karen Jean Ferrante has informed the Company that she would retire from the Board at the forthcoming annual general meeting of the Company to be held on May 12, 2023, and that she would not be seeking re-election at the AGM so that she could devote more time to her personal engagements.

Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2023 financial results will be released before the market opens on Monday, May 15, 2023.

Sonoma Pharmaceuticals, Inc. today announced the launch of Podiacyn TM Advanced Everyday Foot Care direct to consumers for over-the-counter use in the United States.

Blue-Zone Technologies Ltd. announced it has signed an agreement with Respirair Global LLC to install its patented capture technology in Respirair’s manufacturing facility.

Sanofi has simplified its contractual arrangements relating to the development and commercialization of Beyfortus in the United States.